This bill instructs the Comptroller General to study how the Department of Veterans Affairs furnishes medical care for veterans experiencing perimenopause, genitourinary syndrome of menopause, and menopause, specifically focusing on services provided under sections 1703 and 1710 of title 38. The study must produce a public report within 18 months that inventories current care, reviews VA guidelines and provider training, evaluates access and quality (including veteran feedback), examines outreach and research use, and issues recommendations.
Following the GAO report, the bill requires the Secretary of Veterans Affairs to deliver a strategic plan to relevant Congressional committees within six months describing how the VA will implement the GAO recommendations and improve both access to and quality of menopause-related care. The measure is narrowly procedural: it mandates study and planning rather than prescribing clinical standards or funding.
At a Glance
What It Does
Directs the Comptroller General to study menopause-related medical services the VA furnishes (perimenopause, genitourinary syndrome of menopause, menopause) and to issue a public report within 18 months containing specified elements and recommendations. Requires the VA Secretary to submit a strategic implementation plan within six months of that report.
Who It Affects
Women and trans veterans seeking menopause-related care, VA clinicians and clinic administrators responsible for primary care and specialty referrals, VA research and education offices, and Congressional Veterans’ Affairs committees that will receive the report and plan.
Why It Matters
The bill establishes an evidence-gathering and planning process focused on a historically under-examined area of veterans’ health. For VA managers and compliance officers, it creates a near-term reporting and planning obligation and signals potential future operational or policy changes based on GAO recommendations.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
The legislation charges the Comptroller General with a targeted study of menopause-related medical services the Department of Veterans Affairs provides under two statutory authorities in title 38. The study must assess care for perimenopause, genitourinary syndrome of menopause, and menopause stages — not general women’s health — and must examine how the VA currently diagnoses, treats, trains clinicians, refers patients externally, and communicates available options to veterans.
The statute enumerates the concrete elements the GAO report must include: an inventory of services as they exist at enactment; a review of VA clinical guidelines and provider training; an evaluation of access to interdisciplinary care; an assessment of outreach and education efforts; a quality review drawing on veteran feedback and measures of treatment efficacy; an examination of how VA research is leveraged to improve care; and recommendations for improvement. The Comptroller General must publish that report within 18 months of enactment.After publication, the VA has a six-month window to return to Congress with a strategic plan describing how it will implement the GAO’s recommendations and strengthen both access and quality for menopause care furnished under the cited statutory authorities.
The bill does not itself change eligibility rules in title 38, nor does it appropriate funds or impose clinical mandates; its legal effect is to create a structured review and a required VA planning response that could form the basis for later policy or budgetary action.
The Five Things You Need to Know
The Comptroller General must study VA medical services for perimenopause, genitourinary syndrome of menopause, and menopause that are furnished under sections 1703 and 1710 of title 38.
The GAO report must be made public no later than 18 months after the bill becomes law and must include an inventory of services, reviews of guidelines and training, and recommendations.
Report elements explicitly require evaluation of access to interdisciplinary care, veteran feedback on quality, and the VA’s use of research to improve menopause treatment.
Within six months after the GAO report is made public, the Secretary of Veterans Affairs must submit a strategic plan to the House and Senate Veterans’ Affairs Committees describing how the VA will implement the recommendations and improve access and quality.
The bill mandates study and planning only: it does not create new clinical entitlements, appropriate funding, or change statutory eligibility for VA care.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Short title
Establishes the act’s name as the "Improving Menopause Care for Veterans Act of 2025." This is purely nominal but provides the reference used in subsequent reporting and congressional communications.
GAO study scope
Directs the Comptroller General to carry out a study focused specifically on medical services the VA furnishes for perimenopause, genitourinary syndrome of menopause, and menopause stages under 38 U.S.C. §§1703 and 1710. Practically, this instructs GAO to limit its data collection and analysis to services tied to those statutory authorities rather than broader women’s health programs, which shapes the universe of facility-level programs, claims, and provider activities GAO will review.
Report deadline and required elements
Requires GAO to publish its report within 18 months of enactment and specifies discrete elements the report must address: a description of current VA menopause care; review of VA protocols and provider training; assessment of referral practices to non-VA providers; evaluation of access to interdisciplinary care; review of outreach and education to veterans; assessment of quality including veteran feedback and treatment efficacy; analysis of VA use of research to improve care; and recommendations. These enumerated items create a checklist GAO must follow and will shape the evidence GAO gathers (e.g., training curricula, referral logs, patient surveys).
VA strategic plan requirement
Obligates the Secretary of Veterans Affairs to submit a strategic plan within six months after GAO’s report is publicly released. The plan must explain how the VA will implement GAO’s recommendations and improve access and quality for menopause care under the specified statutory authorities. The provision turns GAO’s findings into an executive-branch planning obligation but leaves the content and resourcing of implementation to the VA and subsequent appropriations or internal reallocation decisions.
This bill is one of many.
Codify tracks hundreds of bills on Veterans across all five countries.
Explore Veterans in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Women and trans veterans experiencing perimenopause or menopause — will see a formal federal examination of care availability, quality, and outreach that can surface gaps and lead to concrete VA planning to address unmet needs.
- VA health system planners and clinical leaders — receive structured, evidence-based recommendations and a required planning timeline that can justify program development, training initiatives, or requests for resources.
- Veteran advocacy organizations focused on women's health — gain authoritative GAO findings and recommendations to support advocacy for program changes, funding, or policy updates.
Who Bears the Cost
- Department of Veterans Affairs administration — must assemble data, respond to GAO inquiries, and create a strategic plan within a six-month window, consuming personnel time and possibly internal resources.
- VA clinicians and facility managers — may face additional data-collection burdens (training records, referral documentation, patient feedback) during GAO’s study and as the VA implements recommendations.
- Congressional committees and oversight staff — will need to review the GAO report and the VA plan and may be pressured to draft follow-up legislation or appropriations, creating oversight workload and potential resource commitments.
Key Issues
The Core Tension
The central dilemma is between systematically studying and documenting gaps in VA menopause care to create an evidence-based improvement path, and the urgent clinical needs of veterans that may require immediate operational changes; a time-consuming study and planning process can produce better long-term solutions but risks postponing practical fixes in the near term without dedicated funding.
The bill is procedural rather than prescriptive: it creates a fact-finding and planning sequence but does not earmark funding or mandate specific clinical changes. That design limits immediate impact — GAO can identify shortcomings and the VA must plan, but actual improvements will likely require separate budgetary or regulatory actions.
This raises a practical risk that the study delays urgent operational fixes because stakeholders may await GAO’s recommendations rather than pursue interim solutions.
Implementation questions persist around scope and evidence. The statute ties the study to care furnished under two title 38 sections without defining which programs, contracts, or community care arrangements fall within GAO’s purview; that could produce disputes about data completeness.
Additionally, measuring “efficacy” and “quality” of menopause care requires clinical outcome metrics that the VA may not currently collect, meaning GAO might rely on process measures, patient satisfaction, or limited prior research. Finally, the bill creates no funding stream for recommended changes, so VA leaders will need to translate the plan into budget requests or reprioritize existing resources to act on improvements.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.